Dr. Thomas Galloway, MD
Claim this profileFox Chase Cancer Center
Area of expertise
Squamous Cell Carcinoma
Thomas Galloway, MD has run 8 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Oropharyngeal Carcinoma
Thomas Galloway, MD has run 5 trials for Oropharyngeal Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Fox Chase Cancer Center
Temple University Hospital
Clinical Trials Thomas Galloway, MD is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting
1 award
Phase 2
31 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting
1 award
Phase 2
19 criteria
More about Thomas Galloway, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Thomas Galloway, MD has experience with
- Cisplatin
- Pembrolizumab
- Intensity-Modulated Radiation Therapy
- Radiation Therapy
- Reirradiation
- Stereotactic Body Radiation Therapy (SBRT)
Breakdown of trials Thomas Galloway, MD has run
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Throat Cancer
Laryngeal Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Galloway, MD specialize in?
Thomas Galloway, MD focuses on Squamous Cell Carcinoma and Oropharyngeal Carcinoma. In particular, much of their work with Squamous Cell Carcinoma has involved p16 negative patients, or patients who are Stage III.
Is Thomas Galloway, MD currently recruiting for clinical trials?
Yes, Thomas Galloway, MD is currently recruiting for 4 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Thomas Galloway, MD has studied deeply?
Yes, Thomas Galloway, MD has studied treatments such as Cisplatin, Pembrolizumab, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Thomas Galloway, MD?
Apply for one of the trials that Thomas Galloway, MD is conducting.
What is the office address of Thomas Galloway, MD?
The office of Thomas Galloway, MD is located at: Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 United States. This is the address for their practice at the Fox Chase Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.